Mary Kay Inc. Topical Skin Care Formulation Patent US12605308B2
Summary
Mary Kay Inc. received US Patent 12605308B2 on April 21, 2026, covering topical skin care formulations containing Ficus lacor extract. The patent protects a method of reducing oxidation or MMP-1 activity in skin through topical application of the extract. The filing date was October 18, 2023, and the patent contains 22 claims.
“A method for treating skin of a person in need thereof is disclosed. The method includes topically applying to the skin of the person a composition comprising an effective amount of an aqueous, alcoholic, or aqueous-alcoholic extract from Ficus lacor, wherein the extract from Ficus lacor reduces oxidation in the skin or reduces MMP-1 activity in the skin.”
About this source
GovPing monitors USPTO Patent Grants - Pharma (A61K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 22 changes logged to date.
What changed
The USPTO granted patent US12605308B2 to Mary Kay Inc. on April 21, 2026, covering a method for treating skin by topically applying a composition containing an effective amount of an aqueous, alcoholic, or aqueous-alcoholic extract from Ficus lacor. The extract is claimed to reduce oxidation in the skin or reduce MMP-1 activity in the skin. This patent gives Mary Kay Inc. exclusive rights to this formulation for skin care applications.
For competitors in the skin care and cosmetics industry, this patent represents a potential barrier to developing similar botanical extract-based skin care products using Ficus lacor. Companies developing anti-aging or skin protection products may need to either design around this patent or explore licensing arrangements with Mary Kay Inc.
Archived snapshot
Apr 22, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Topical skin care formulations comprising plant extracts
Grant US12605308B2 Kind: B2 Apr 21, 2026
Assignee
MARY KAY INC.
Inventors
Tiffany Carle, David Gan, Michelle Hines
Abstract
A method for treating skin of a person in need thereof is disclosed. The method includes topically applying to the skin of the person a composition comprising an effective amount of an aqueous, alcoholic, or aqueous-alcoholic extract from Ficus lacor, wherein the extract from Ficus lacor reduces oxidation in the skin or reduces MMP-1 activity in the skin.
CPC Classifications
A61K 8/022
Filing Date
2023-10-18
Application No.
18381436
Claims
22
Mentioned entities
Related changes
Get daily alerts for USPTO Patent Grants - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.